Exhaled nitric oxide levels to guide treatment for adults with asthma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD011440.pub2PMID 27580628PMCID PMC6457753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?

  2016cited by this paper
• Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review

  2016cited by this paper
• A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma

  2016cited by this paper
• Exhaled nitric oxide levels to guide treatment for children with asthma.

  2016cited by this paper
• Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial

  2016cited by this paper
• Fractional Exhaled Nitric Oxide Monitoring Does Not Improve Asthma Management in Children with Concordant and Discordant Asthma Phenotypes.

  2015cited by this paper
• FeNO and Asthma Treatment in Children

  2015cited by this paper
• Response to the Editor: “Fractional exhaled nitric oxide‐guided algorithm for children with allergic asthma”

  2015cited by this paper
• Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.

  2015cited by this paper
• 83: Management of Infants with Neonatal Abstinence Syndrome

  2015cited by this paper
• Monitoring strategies in children with asthma: a randomised controlled trial

  2015cited by this paper
• A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country

  2015cited by this paper
• Cost-effectiveness of FeNO- and web-based monitoring in pediatric asthma management

  2015cited by this paper
• Fractional exhaled nitric oxide‐guided algorithm for children with asthma

  2015cited by this paper
• Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.

  2015cited by this paper
• Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life

  2015cited by this paper
• The influence of asthma control on psychosocial outcomes for pregnant women with asthma

  2015cited by this paper
• Exhaled nitric oxide in childhood allergic asthma management: A randomised controlled trial

  2014cited by this paper
• Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial

  2014cited by this paper
• FeNO and web-based monitoring in paediatric asthma managemant; the BATMAN study

  2013cited by this paper
• Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial

  2013cited by this paper
• Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.

  2013cited by this paper
• Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.

  2012cited by this paper
• Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.

  2012cited by this paper
• Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial.

  2011cited by this paper
• Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial

  2011cited by this paper
• An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

  2011cited by this paper
• FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management

  2010cited by this paper
• Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.

  2009cited by this paper
• Clinical use of exhaled nitric oxide measurements.

  2009cited by this paper
• Status of Childhood Asthma in the United States, 1980–2007

  2009cited by this paper
• Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.

  2009cited by this paper
• Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma.

  2009cited by this paper
• Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

  2008cited by this paper
• Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma.

  2008cited by this paper
• Exhaled nitric oxide in guideline-based asthma management.

  2008cited by this paper
• The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.

  2007cited by this paper
• 50 years of asthma: UK trends from 1955 to 2004

  2006cited by this paper
• International trends in admissions and drug sales for asthma.

  2006cited by this paper
• Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.

  2006cited by this paper
• Exhaled nitric oxide in the management of childhood asthma: A prospective 6‐months study

  2006cited by this paper
• Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

  2005cited by this paper
• Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial.

  2005cited by this paper
• Comparison of exhaled nitric oxide analysers.

  2005cited by this paper
• ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

  2005cited by this paper
• Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

  2005cited by this paper
• Does environmental endotoxin exposure prevent asthma?

  2002cited by this paper
• Non-eosinophilic asthma: importance and possible mechanisms

  2002cited by this paper
• Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma

  2002cited by this paper
• Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship

  2002cited by this paper
• The health economics of asthma and rhinitis. I. Assessing the economic impact.

  2001cited by this paper
• The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control.

  2001cited by this paper
• Eosinophils in asthma and other allergic diseases.

  2000cited by this paper
• Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial.

  2000cited by this paper
• Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

  1999cited by this paper
• Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma.

  1998cited by this paper
• Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

  1998cited by this paper
• Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients.

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper

• Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the bronchodilator response

  2025cites this paper
• Precision Medicine in Asthma: The Role of Biomarkers

  2025cites this paper
• Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers

  2024cites this paper
• Breath and Sputum Analyses in Asthmatic Patients: An Overview

  2024cites this paper
• Longitudinal changes in biomarker levels: an important part of asthma follow-up.

  2024cites this paper
• Current technological advancement in asthma care

  2024cites this paper
• Medication Adherence in Children with Asthma

  2024cites this paper
• Utility of exhaled nitric oxide to guide mild asthma treatment in atopic patients and its correlation with asthma control test score: a randomized controlled trial

  2024cites this paper
• Allergen immunotherapy: progress and future outlook

  2023cites this paper
• Nitric oxide hinders club cell proliferation through Gdpd2 during allergic airway inflammation

  2023cites this paper
• Exhaled nitric oxide (FeNO): Bridging a knowledge gap in asthma diagnosis and treatment

  2023cites this paper
• The treatable traits approach to adults with obstructive airways disease in primary and secondary care

  2023cites this paper
• Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases

  2023cites this paper
• Approaches to Management of Asthma: Guidelines for Stepped Care and Self-Monitoring.

  2023cites this paper
• ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)

  2023cites this paper
• Effectiveness of FeNO‐guided treatment in adult asthma patients: A systematic review and meta‐analysis

  2023cites this paper
• New perspectives of biological therapy for severe asthma in adults and adolescents.

  2022cites this paper
• Exhaled nitric oxide in asthma: from diagnosis to management

  2022cites this paper
• Randomised controlled trials utilising FENO to manage asthma: is it time to acknowledge that “one size does not fit all”?

  2022cites this paper
• Longitudinal hierarchical Bayesian models of covariate effects on airway and alveolar nitric oxide

  2022cites this paper
• Critical evaluation of asthma biomarkers in clinical practice

  2022cites this paper
• Effect of General Anesthesia Maintenance with Propofol or Sevoflurane on Fractional Exhaled Nitric Oxide and Eosinophil Blood Count: A Prospective, Single Blind, Randomized, Clinical Study on Patients Undergoing Thyroidectomy

  2022cites this paper
• What is the added value of FeNO as T2 biomarker?

  2022cites this paper
• Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes

  2022cites this paper
• Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma

  2022cites this paper
• Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews

  2022cites this paper
• [Digital tools for remote monitoring of asthma patients: Gadgets or revolution?]

  2022cites this paper
• Personalized treatment of asthma: the importance of sex and gender differences.

  2022cites this paper
• NO in de uitgeademde lucht, een overzicht

  2022cites this paper
• Recent Advances in Long-Term Management of Asthma

  2022cites this paper
• Treatment Response Biomarkers in Asthma and COPD

  2021cites this paper
• Recommandations pour la prescription et l’interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 4 : allergie aux médicaments

  2021cites this paper
• Risk factors for asthma attacks and poor control in children: a prospective observational study in UK primary care

  2021cites this paper
• Electrochemical monitoring of bronchial inflammation in pediatric athletes: A prospective study

  2021cites this paper
• Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.

  2021cites this paper
• Phenotype-Guided Asthma Therapy: An Alternative Approach to Guidelines

  2021cites this paper
• Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review

  2021cites this paper
• Recommandations pour la prescription et l’interprétation des examens biologiques utilisables dans le cadre du diagnostic ou du suivi des allergies, disponibles en France. Partie 1 : préambule

  2021cites this paper
• Application of exhaled nitric oxide (FeNO) in pediatric asthma

  2021cites this paper
• Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma

  2020cites this paper
• Consenso mexicano en relación con la fracción exhalada de óxido nítrico (FeNO) en asma 2020

  2020cites this paper
• Biomarker‐guided management reduces exacerbations in non‐eosinophilic asthma in pregnancy: A secondary analysis of a randomized controlled trial

  2020cites this paper
• Exhaled nitric oxide as a predictor of the effectiveness of basic therapy for bronchial asthma in children

  2020cites this paper
• Factors associated with exhaled nitric oxide in children with asthma and allergic rhinitis

  2020cites this paper
• Spirometry and FeNO testing for asthma in children in UK primary care: a prospective observational cohort study of feasibility and acceptability.

  2020cites this paper
• Cost-utility of use of sputum eosinophil counts to guide management in children with asthma

  2020cites this paper
• [Mexican consensus on fractional exhaled nitric oxide (FeNO) in asthma 2020].

  2020cites this paper
• An Optimistic Vision of Future: Diagnosis of Bacterial Infections by Sensing Their Associated Volatile Organic Compounds

  2020cites this paper
• Determination of the cutoff values of Th2 markers for the prediction of future exacerbation in severe asthma: An analysis from the Hokkaido Severe Asthma Cohort Study.

  2020cites this paper
• Personalised exhaled nitric oxygen fraction (FENO)-driven asthma management in primary care: a FENO subgroup analysis of the ACCURATE trial

  2020cites this paper
• A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future

  2020cites this paper
• More options for managing severe asthma in adults.

  2020cites this paper
• Combination of Fractional Exhaled Nitric Oxide (FeNO) Level and Asthma Control Test (ACT) in Detecting GINA-Defined Asthma Control in Treated Asthmatic Patients in Vietnam

  2020cites this paper
• Chronic Rhinosinusitis and Concomitant Medical Disorders

  2020cites this paper
• Asthma bronchiale

  2020cites this paper
• An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice.

  2020cites this paper
• Clinical Values of Nitric Oxide Parameters from the Respiratory System.

  2020cites this paper
• How do Cochrane authors conduct web searching to identify studies? Findings from a cross-sectional sample of Cochrane Reviews.

  2020cites this paper
• Biomarkers of type 2 airway inflammation as predictors of loss of asthma control during step-down therapy for well-controlled disease: The Long Acting Beta Agonist Step-down Study (LASST).

  2020cites this paper
• Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.

  2020cites this paper
• Exhaled nitric oxide as a guiding tool for bronchial asthma: A randomised controlled trial.

  2020cites this paper
• Chronic asthma in adults

  2020cites this paper
• Clinical utility of fractional exhaled nitric oxide in severe asthma management

  2020cites this paper
• Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)

  2020cites this paper
• Changes in fractional exhaled nitric oxide, exhaled carbon monoxide and pulmonary function during the acute attack, treatment and remission phases of pediatric asthma

  2020cites this paper
• Physiological tests of small airways function in diagnosing asthma: a systematic review

  2020cites this paper
• A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries.

  2020cites this paper
• Differences between patients who achieved asthma control and those who remain uncontrolled after standardized severe asthma care strategy

  2020cites this paper
• The Value of Inflammatory Biomarkers in Differentiating Asthma–COPD Overlap from COPD

  2020cites this paper
• The Use of Non-Tumor-Related Liquid Biopsy in Respiratory Medicine.

  2019cites this paper
• Exhaled breath testing - A tool for the clinician and researcher.

  2019cites this paper
• Respiratory symptoms, asthma and levels of fractional exhaled nitric oxide in schoolchildren in the industrial areas of Estonia.

  2019cites this paper
• Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma

  2019cites this paper
• The Asthma Controller Step-down Yardstick.

  2019cites this paper
• Severe asthma in children: Evaluation and management.

  2019cites this paper
• Urinary organic acids as biomarkers in the assessment of pulmonary function in children with asthma.

  2019cites this paper
• School-aged asthma children with high fractional exhaled nitric oxide levels and lung dysfunction are at high risk of prolonged lung dysfunction

  2019cites this paper
• Use of Symptoms Scores, Spirometry, and Other Pulmonary Function Testing for Asthma Monitoring

  2019cites this paper
• Measurement of FeNO in asthma: what the hospital doctor needs to know.

  2019cites this paper
• The effect of passive smoking on exhaled nitric oxide in asthmatic children.

  2019cites this paper
• Basic characteristics and clinical value of FeNO in smoking asthmatics—a systematic review

  2019cites this paper
• Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests

  2019cites this paper
• The Immunopathogenesis of Asthma

  2019cites this paper
• Asthma and Chronic Rhinosinusitis: Diagnosis and Medical Management

  2019cites this paper
• Toward clinically applicable biomarkers for asthma: An EAACI position paper

  2019cites this paper
• Approaches to Asthma Diagnosis in Children and Adults

  2019cites this paper
• Fractional Exhaled Nitric Oxide-Assisted Management of Uncontrolled Persistent Asthma: A Real-World Prospective Observational Study.

  2019cites this paper
• Exhaled nitric oxide in chronic cough: A good tool in a multi-step approach.

  2019cites this paper
• History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children

  2019cites this paper
• Phenotypes favoring fractional exhaled nitric oxide discordance vs guideline-based uncontrolled asthma.

  2019cites this paper
• Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.

  2019cites this paper
• Evaluation of the accuracy of FeNO in pediatric asthma diagnosis : a meta-analysis

  2019cites this paper
• Diagnostic and prognostic markers in adult-onset asthma

  2019influential citation
• Clinical biomarkers and noninvasive assessment of severe asthma

  2019cites this paper
• Symptoms and perception of airway obstruction in asthma: clinical implications for use of reliever medications.

  2019cites this paper
• Different Relationships between FENO and COPD Characteristics in Smokers and Ex-Smokers

  2019cites this paper
• The Impact of the Global Initiative for Asthma (GINA): Compass, Concepts, Controversies and Challenges

  2019cites this paper
• 소아 천식 조절 지표로서의 기관지확장제반응의 유용성

  2019cites this paper
• The use of non-tumor-related liquid biopsy in respiratory medicine

  2019cites this paper
• Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)

  2019cites this paper